-
Mashup Score: 6Hodgkin Lymphoma Care With Dr. Evens: Fitness, Frailty as Factors in Elderly Patients | Blood Cancers Today - 7 day(s) ago
Andrew Evens, DO, MSc, FACP, discusses tailoring management by patient fitness in this setting plus recent clinical trials.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 1Acute Myeloid Leukemia | Blood Cancers Today - 8 day(s) ago
Acute myeloid leukemia (AML), the most common acute leukemia in adults, can occur when myeloid cells form abnormal myeloblast instead of developing into normal mature blood cells.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet-
🤔 What's new in acute myeloid leukemia? ✔️ From regulatory approvals to expert interviews with @chadinabhan, @scheinbp, @DrGwenNichols, @AfafOsman7, and more, check out our #AML coverage on our website! ➡️ https://t.co/gKq0uA0x28 https://t.co/WDiRY1O84T
-
-
Mashup Score: 0
San Antonio, TX – November 6, 2024 – Mitotech Ltd., a clinical-stage biotechnology company focused on mitochondria-based therapies, presented compelling new weight loss data for its investigational compound SkQ1 at ObesityWeek® 2024. The conference, held November 2-6, 2024, in San Antonio, Texas, is a premier event for the latest scientific advancements in obesity research and treatment. SkQ1 is a dual-action mitochondria-targeted mild uncoupling catalyst and ferroptosis inhibitor, designed to address
Source: www.biospace.comCategories: General Medicine News, Hematologists1Tweet-
Mitotech Unveils Promising New OBESTITY TREATMENT Data on SkQ1 at ObesityWeek® 2024 - BioSpace. I was on a trial with this a few years ago. It did wonders for my dry eyes https://t.co/pTIxxrajGh
-
-
Mashup Score: 21Impact of the COVID‐19 pandemic on treatment of patients with acute myeloid leukaemia in India - 9 day(s) ago
During the COVID-19 pandemic, our findings highlight changes in AML management strategies in India. There was a decrease in overall patient registrations, particularly at large referral centers, whil…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hematologists1Tweet-
https://t.co/wqLytJM9xy HCC data on 'Impact of COVID on AML treatment patterns and outcomes in India' - @HCC_HemeCancer @ManjuSengar7
-
-
Mashup Score: 24Subscribe | Blood Cancers Today - 10 day(s) ago
Sign up for Blood Cancers Today eNewsletters to join an extensive community of hematologic oncology professionals and get the latest news and insights from the field.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet-
Don't miss the new episode of The HemOnc Pulse on July 27 featuring @NitinJainMD discussing venetoclax and combo therapies in #CLL with host @chadinabhan. Subscribe to all of the latest news in heme onc at: https://t.co/aEpyHK3DF2 @MDAndersonNews @SocietyofHemOnc https://t.co/zuo9EnBk8l
-
-
Mashup Score: 0Pacritinib Superior to Best Available Therapy for Myelofibrosis Patients With Thrombocytopenia, Anem | Blood Cancers Today - 12 day(s) ago
Pacritinib demonstrated superiority to best available therapy for spleen volume reduction, total symptom score, and transfusion independence response.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet-
☑️ Full-dose pacritinib is efficacious in terms of spleen volume reduction, symptoms, and transfusion response in patients with #myelofibrosis with #thrombocytopenia and #anemia. 📰 Read more from the study led by @pankitvachhani of @ONealCancerUAB. ➡️ https://t.co/DwjuLbKDkv https://t.co/aHQexbGesV
-
-
Mashup Score: 10Meeting News | Blood Cancers Today - 17 day(s) ago
The online home of the latest conference coverage and meeting news for hematologic oncologists. View the latest news on Blood Cancers Today.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet-
Our BCT editors are already gearing up for #ASH23, happening from December 9-12 in San Diego! @ASH_hematology Stay updated on meeting news here: https://t.co/4NzzFccn6P What are you most looking forward to at ASH? Share below! ⬇️ ⬇️ https://t.co/GtxlBVTu3P
-
-
Mashup Score: 10
Nature – Uprooting stem cells from their native environment and transplanting them to other individuals exaggerates selective pressures, distorting and accelerating the loss of clonal diversity in…
Source: www.nature.comCategories: General Medicine News, Hematologists1Tweet-
RT @Wang_Yu_Hung: Clonal dynamics after allogeneic haematopoietic cell transplantation https://t.co/Y0BZdWIXNO #BMTsm @Nature @TheEBMT @Moh…
-
-
Mashup Score: 1User account | Research To Practice - 24 day(s) ago
Research To Practice requires users to log in to view educational content. All content is available without
Source: www.researchtopractice.comCategories: General Medicine News, Hematologists1Tweet-
Check out the proceedings from a webinar hosted last month by Dr Neil Love on the role of BTK inhibitors in the management of mantle cell lymphoma. https://t.co/f3zP38DG3K https://t.co/8yJpcdx6Gu
-
-
Mashup Score: 4Largest Real-World Cohort Study of Liso-Cel for Richter Transformation Presented | Blood Cancers Today - 25 day(s) ago
The authors found the complete response rate results to be promising and to warrant further clinical investigation.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet-
Liso-cel provided meaningful clinical benefit in patients with Richter Transformation, with low incidences of grade 3 or higher CRS and ICANS. The study was led by @AllisonM_Winter, of @ClevelandClinic, and published in @JCO_ASCO. ➡️ https://t.co/nkgGXXGDwr https://t.co/ODOGenoJU0
-
🙌 @DrAEvens, of @RutgersCancer @rutgershealth @RWJBarnabas, hopped on the @BloodCancerTalk podcast with @rajshekharucms, @AshKishtagari, and @Eddie_Cliff! 🎙️ On this episode, they discuss the management of Hodgkin lymphoma in older patients. 🎧➡️ https://t.co/AydlBdBQcn https://t.co/SqffRQqgpu